药品注册申请号:040159
申请类型:ANDA (仿制药申请)
申请人:BARR
申请人全名:BARR LABORATORIES INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 MEDROXYPROGESTERONE ACETATE MEDROXYPROGESTERONE ACETATE TABLET;ORAL 2.5MG No No AB 1996/08/09 1996/08/09 Prescription
002 MEDROXYPROGESTERONE ACETATE MEDROXYPROGESTERONE ACETATE TABLET;ORAL 5MG No No AB 1996/08/09 Prescription
003 MEDROXYPROGESTERONE ACETATE MEDROXYPROGESTERONE ACETATE TABLET;ORAL 10MG No No AB 1996/08/09 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2024/09/16 SUPPL-34(补充) Approval Labeling STANDARD
2021/06/07 SUPPL-29(补充) Approval Labeling STANDARD
2007/12/26 SUPPL-23(补充) Approval Labeling
2002/04/10 SUPPL-21(补充) Approval Manufacturing (CMC)
2001/12/14 SUPPL-19(补充) Approval Manufacturing (CMC)
2001/10/26 SUPPL-20(补充) Approval Labeling
2000/05/16 SUPPL-18(补充) Approval Manufacturing (CMC)
2000/01/24 SUPPL-15(补充) Approval Manufacturing (CMC)
1999/12/21 SUPPL-16(补充) Approval Manufacturing (CMC)
1999/09/24 SUPPL-17(补充) Approval Labeling
1999/07/07 SUPPL-14(补充) Approval Labeling
1999/05/20 SUPPL-13(补充) Approval Manufacturing (CMC)
1999/03/26 SUPPL-12(补充) Approval Labeling
1999/03/26 SUPPL-11(补充) Approval Manufacturing (CMC)
1999/03/11 SUPPL-7(补充) Approval Manufacturing (CMC)
1999/02/05 SUPPL-9(补充) Approval Manufacturing (CMC)
1998/12/01 SUPPL-8(补充) Approval Manufacturing (CMC)
1998/09/25 SUPPL-6(补充) Approval Manufacturing (CMC)
1998/09/25 SUPPL-5(补充) Approval Manufacturing (CMC)
1996/12/27 SUPPL-1(补充) Approval Manufacturing (CMC)
1996/08/09 ORIG-1(原始申请) Approval
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:MEDROXYPROGESTERONE ACETATE 剂型/给药途径:TABLET;ORAL 规格:2.5MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
011839 001 NDA PROVERA MEDROXYPROGESTERONE ACETATE TABLET;ORAL 2.5MG Prescription Yes No AB Approved Prior to Jan 1, 1982 PFIZER
040159 001 ANDA MEDROXYPROGESTERONE ACETATE MEDROXYPROGESTERONE ACETATE TABLET;ORAL 2.5MG Prescription No No AB 1996/08/09 BARR
活性成分:MEDROXYPROGESTERONE ACETATE 剂型/给药途径:TABLET;ORAL 规格:5MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
011839 003 NDA PROVERA MEDROXYPROGESTERONE ACETATE TABLET;ORAL 5MG Prescription Yes No AB Approved Prior to Jan 1, 1982 PFIZER
040159 002 ANDA MEDROXYPROGESTERONE ACETATE MEDROXYPROGESTERONE ACETATE TABLET;ORAL 5MG Prescription No No AB 1996/08/09 BARR
活性成分:MEDROXYPROGESTERONE ACETATE 剂型/给药途径:TABLET;ORAL 规格:10MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
011839 004 NDA PROVERA MEDROXYPROGESTERONE ACETATE TABLET;ORAL 10MG Prescription Yes Yes AB Approved Prior to Jan 1, 1982 PFIZER
040159 003 ANDA MEDROXYPROGESTERONE ACETATE MEDROXYPROGESTERONE ACETATE TABLET;ORAL 10MG Prescription No No AB 1996/08/09 BARR
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database